# Larimar Therapeutics, Inc.: Form 8-K, filed Sep 29, 2026

- Company: [Larimar Therapeutics, Inc.](/companies/lrmr.md) (CIK 1374690)
- Form: 8-K
- Filed: 2026-09-29
- Accepted by EDGAR: Sep 29, 2026, 20:06 ET
- Period: 2026-09-29
- Accession: 0001193125-26-407331
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1374690/000119312526407331/lrmr-20260929.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1374690/000119312526407331/

## Items reported

- Item 5.02: Departure or appointment of officers or directors

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1374690/000119312526407331/lrmr-20260929.htm

Filed Sep 29, 2026.
Source: SEC EDGAR, the filing index for accession 0001193125-26-407331. Last ingested by Listed: Oct 24, 2026, 15:12 ET. No prices; not investment advice.